[Mengke Pharmaceutical: application for clinical trial of MRX-4 sequential contezolamide tablets for injection approved by European, Asian and Latin American countries] Science and Technology Innovation Board Daily on the 18th, Mengke Pharmaceutical announced that the application for clinical trials of MRX-4 sequential contezolid tablets for injection in diabetic foot infection submitted by the company in European, Asian and Latin American countries has been approved by 6 countries. Clinical trials are allowed in Israel, Bulgaria, Slovakia, Croatia, Poland and Brazil.